Herc 4 inhibitors belong to a class of chemical compounds designed to selectively target and inhibit the activity of the protein known as HERC4, which stands for HECT and RLD domain-containing E3 ubiquitin-protein ligase 4. HERC4 is a member of the HERC family of E3 ubiquitin ligases, which are enzymes responsible for tagging proteins with ubiquitin molecules, marking them for degradation by the proteasome or regulating their cellular functions. In particular, HERC4 is involved in ubiquitinating various target proteins, making it an essential player in the ubiquitin-proteasome system.
These inhibitors have become invaluable tools for researchers studying the intricate regulatory mechanisms of protein degradation and cellular homeostasis. By selectively inhibiting HERC4, scientists can investigate the specific substrates and cellular processes that are influenced by this E3 ubiquitin ligase. Understanding the role of HERC4 in protein degradation and cellular signaling pathways is essential for unraveling its contributions to various biological processes. The development of Herc 4 inhibitors offers promising avenues for scientific exploration in fields such as molecular biology, cell biology, and drug discovery. Researchers can use these inhibitors to gain insights into the role of HERC4 in various cellular processes and to dissect the consequences of its dysregulation in pathological conditions. Additionally, they provide an opportunity to better understand the intricacies of the ubiquitin-proteasome system, a fundamental aspect of cellular regulation with relevance to numerous diseases.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that prevents protein degradation, which might indirectly impact Herc4 activity. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Inhibits the proteasome and can impact ubiquitin-proteasome system functionality. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor, affecting protein degradation pathways. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Modulates the activity of E3 ubiquitin ligases, potentially affecting Herc4 indirectly. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Stabilizes p53 by inhibiting its ubiquitination, affecting the ubiquitin-proteasome system. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
A vacuolar type H+-ATPase inhibitor affecting lysosomal degradation. | ||||||
Exo1 | 461681-88-9 | sc-200752 sc-200752A | 10 mg 50 mg | $84.00 $297.00 | 4 | |
A ubiquitin-specific protease inhibitor, can influence ubiquitination processes. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
A selective proteasome inhibitor, affecting protein degradation. | ||||||
MLN7243 | 1450833-55-2 | sc-507338 | 5 mg | $340.00 | ||
An inhibitor of the ubiquitin-activating enzyme UBA1, affecting ubiquitination processes. | ||||||